KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Discontinued OperationsCash from Discontinued OperationsCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Receivables (2016 - 2022)

TherapeuticsMD filings provide 13 years of Change in Receivables readings, the most recent being -$13.6 million for Q3 2022.

  • On a quarterly basis, Change in Receivables fell 439.82% to -$13.6 million in Q3 2022 year-over-year; TTM through Sep 2022 was -$4.3 million, a 130.19% decrease, with the full-year FY2021 number at $4.3 million, down 47.39% from a year prior.
  • Change in Receivables hit -$13.6 million in Q3 2022 for TherapeuticsMD, down from $11.1 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $11.1 million in Q2 2022 to a low of -$13.6 million in Q3 2022.
  • Median Change in Receivables over the past 5 years was $790885.0 (2018), compared with a mean of $1.6 million.
  • Biggest five-year swings in Change in Receivables: crashed 2767.32% in 2018 and later surged 48326.09% in 2022.
  • TherapeuticsMD's Change in Receivables stood at -$1.8 million in 2018, then soared by 629.91% to $9.3 million in 2019, then fell by 7.4% to $8.6 million in 2020, then crashed by 114.32% to -$1.2 million in 2021, then tumbled by 1006.81% to -$13.6 million in 2022.
  • The last three reported values for Change in Receivables were -$13.6 million (Q3 2022), $11.1 million (Q2 2022), and -$489000.0 (Q1 2022) per Business Quant data.